[
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 12:29 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 12:29 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 12:29 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 12:29 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T04:31:04+00:00",
    "headline": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
    "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
    "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
      "content": {
        "id": "0c1283d4-df14-3ee2-9d0a-6d5623cb5e0c",
        "contentType": "STORY",
        "title": "Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts",
        "description": "",
        "summary": "A new regulatory filing shows that billionaire investor Michael Burry's hedge fund Scion Asset Management purchased five million put options on Palantir Technologies, Inc. (NASDAQ:PLTR) and one million put options on NVIDIA Corp. (NASDAQ:NVDA), among ...",
        "pubDate": "2025-11-05T04:31:04Z",
        "displayTime": "2025-11-05T04:31:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce",
          "originalWidth": 720,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TTciiphdQR88uNeAEBOPyA--~B/aD00ODA7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 720,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pQuyOpoLC5jVJ3Eq2VY_ZA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/benzinga_79/fddb4c00d29ba7af97f6f5e3297816ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "https://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/michael-burry-super-bearish-palantir-043104113.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "LULU"
            },
            {
              "symbol": "SLM"
            },
            {
              "symbol": "TSLA"
            },
            {
              "symbol": "EL"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "MELI"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "HAL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "MOH"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "IDLE-USD"
            },
            {
              "symbol": "OPAI.PVT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T00:37:20+00:00",
    "headline": "Pfizer (PFE) Profit Margins Double—Challenges Bearish View Despite $4.7B Loss and Revenue Headwinds",
    "summary": "Pfizer (PFE) posted notable earnings growth, with net profit margins improving to 15.6%, a lift from the previous period’s 7%. Year-over-year, EPS growth soared 133.3%, marking a sharp reversal from the company’s five-year average decline of 13.2% per year, even as a significant one-off loss of $4.7 billion weighed on the latest results. Looking ahead, investors are weighing the company’s stronger margins and attractive valuation multiples against forecasts for a 3.2% annual decline in...",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "236bf18b-c086-3c32-82b7-502c6d20133d",
      "content": {
        "id": "236bf18b-c086-3c32-82b7-502c6d20133d",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Profit Margins Double—Challenges Bearish View Despite $4.7B Loss and Revenue Headwinds",
        "description": "",
        "summary": "Pfizer (PFE) posted notable earnings growth, with net profit margins improving to 15.6%, a lift from the previous period’s 7%. Year-over-year, EPS growth soared 133.3%, marking a sharp reversal from the company’s five-year average decline of 13.2% per year, even as a significant one-off loss of $4.7 billion weighed on the latest results. Looking ahead, investors are weighing the company’s stronger margins and attractive valuation multiples against forecasts for a 3.2% annual decline in...",
        "pubDate": "2025-11-05T00:37:20Z",
        "displayTime": "2025-11-05T00:37:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QSfydsi7Q.1zNEN99DbEyw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hi2p7oczHh8yTJraqZcczg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/f7c3fa24d3150b866dc98f7b00648685.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-profit-margins-double-003720893.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:32:25+00:00",
    "headline": "PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
    "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2d150d0b-ad11-37ce-b0c3-dc67664e8eec",
      "content": {
        "id": "2d150d0b-ad11-37ce-b0c3-dc67664e8eec",
        "contentType": "STORY",
        "title": "PFE Q3 Deep Dive: Pipeline, Cost Controls, and Business Development Shape Outlook",
        "description": "",
        "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 5.9% year on year to $16.65 billion. On the other hand, the company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.87 per share was 37% above analysts’ consensus estimates.",
        "pubDate": "2025-11-05T05:32:25Z",
        "displayTime": "2025-11-05T05:32:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PFE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o3tZoPUio75qXATbHoc_Hg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5rZqD7vIoFGnsFYAS_Ztw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfe-q3-deep-dive-pipeline-053225703.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Financial News at 3:49 a.m. EST",
    "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
    "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
      "content": {
        "id": "92dfe834-3e17-3aaa-8c05-26f0aa02982f",
        "contentType": "STORY",
        "title": "AP Top Financial News at 3:49 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-financial-news-12-050000779.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-05T05:00:00+00:00",
    "headline": "AP Top Extended Financial Headlines at 3:49 a.m. EST",
    "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
    "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
    "source": "Associated Press Finance",
    "provider": "yfinance",
    "raw": {
      "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
      "content": {
        "id": "b2634554-8ded-3efe-a40e-4b24b3ebe503",
        "contentType": "STORY",
        "title": "AP Top Extended Financial Headlines at 3:49 a.m. EST",
        "description": "",
        "summary": "Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera",
        "pubDate": "2025-11-05T05:00:00Z",
        "displayTime": "2025-11-05T05:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Associated Press Finance",
          "url": "http://www.ap.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ap-top-extended-financial-headlines-050000775.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]